{"api":"v1","generated_at":"2026-10-01T02:44:16.699Z","licence":{"name":"CC BY 4.0","url":"https://creativecommons.org/licenses/by/4.0/","attribution":"TOLL, with a link to the page cited"},"page":"https://tollindex.com/e/api-magentlab-com-api-calc-imwg-response-d88f96","pinned_page":"https://tollindex.com/e/api-magentlab-com-api-calc-imwg-response-d88f96/at/2026-09-30T22-14Z","pinned":false,"method":"https://tollindex.com/ledger/method","snapshot_at":"2026-09-30T22:14:11.940Z","snapshot_stamp":"2026-09-30T22-14Z","endpoint":{"slug":"api-magentlab-com-api-calc-imwg-response-d88f96","canonical_url":"https://api.magentlab.com/api/calc/imwg_response","resource":"https://api.magentlab.com/api/calc/imwg_response","http_method":"POST","type":"http","x402_version":2,"registries":["cdp"],"primary_registry":"cdp","curated_by_coinbase":false,"description":"Kumar 2016 IMWG measurable serum+urine M-protein response. First-match PD, sCR, CR, VGPR, PR, MR, or SD from caller-assigned flags. sCR is CR plus normal FLC ratio and no clonal BM cells by IHC. CR is negative serum and urine IFE, no plasmacytomas, and BMPC <5%. VGPR is electrophoresis-negative or ≥90% serum M-protein reduction with urine M-protein <100 mg/24 h. Not a diagnosis. Not MRD. Not FLC-only. magent does not assay labs.","service_name":"magent","declared_category":null,"declared_tags":["imwg","myeloma","response","hematology","calculator"],"route_template":null,"registry_updated":"2026-09-28T15:13:01.376Z"},"derived":{"note":"fields no registry supplies; TOLL derives them and marks them derived on the page","title":"calc imwg response","category":"other","first_observed_by_toll":"2026-09-28T13:51:25.436Z","last_observed_by_toll":"2026-09-30T22:14:11.940Z","observation_began":"2026-09-10"},"presence":{"listed_now":true,"first_absent_at":null,"delisting_confirmed_at":null,"events":[{"registry":"cdp","at":"2026-09-28T13:51:25.437Z","event":"listed"}]},"accepts":[{"registry":"cdp","ordinal":0,"network":"eip155:8453","asset":"0x833589fcd6edb6e08f4c7c32d4f71b54bda02913","asset_name":"USD Coin","symbol":"USDC","decimals":6,"amount_display":"0.005 USDC","amount_units":0.005,"decimals_known":true,"pay_to":"0x836Be278f1739fB4308091cD1852F7971Bc19Ee2","scheme":"exact"}],"counters":{"observed_at":"2026-09-30T22:14:11.940Z","calls_30d":2,"unique_payers_30d":1,"last_called_at":"2026-09-28T15:13:01.231Z"},"validation":{"latest":{"observed_at":"2026-09-30T09:03:43.864Z","state":"pass","failed_checks":[],"endpoint_http_status":402,"run_id":"daily-2026-09-30"},"uptime":[{"days":7,"observed":3,"passed":3,"ratio":1},{"days":30,"observed":3,"passed":3,"ratio":1},{"days":90,"observed":3,"passed":3,"ratio":1}],"history_90d":[{"observed_at":"2026-09-30T09:03:43.864Z","state":"pass","failed_checks":[],"run_id":"daily-2026-09-30","state_changed":false},{"observed_at":"2026-09-29T21:08:55.459Z","state":"pass","failed_checks":[],"run_id":"daily-2026-09-29","state_changed":false},{"observed_at":"2026-09-28T16:49:34.947Z","state":"pass","failed_checks":[],"run_id":"new-after-daily-2026-09-28","state_changed":true}]},"seller":{"wallet":"0x836Be278f1739fB4308091cD1852F7971Bc19Ee2","page":"https://tollindex.com/seller/0x836Be278f1739fB4308091cD1852F7971Bc19Ee2","endpoints":844,"hosts":1},"reports":0,"registry_record":{"cdp":[{"tags":["imwg","myeloma","response","hematology","calculator"],"type":"http","accepts":[{"asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"name":"USD Coin","version":"2","paymentFlow":"upfront","resourceUrl":"https://api.magentlab.com/api/calc/imwg_response","assetTransferMethod":"eip3009"},"payTo":"0x836Be278f1739fB4308091cD1852F7971Bc19Ee2","amount":"5000","scheme":"exact","network":"eip155:8453","maxTimeoutSeconds":600}],"quality":{"lastCalledAt":"2026-09-28T15:13:01.231Z","l30DaysTotalCalls":2,"l30DaysUniquePayers":1},"resource":"https://api.magentlab.com/api/calc/imwg_response","extensions":{"bazaar":{"info":{"input":{"body":{"items":[{"imwg_pd":false,"bmpc_lt_5":true,"urine_m_pr":false,"urine_m_lt_100":false,"flc_ratio_normal":true,"ife_serum_negative":true,"ife_urine_negative":true,"no_clonal_cells_ihc":true,"plasmacytomas_absent":true,"serum_m_reduction_ge_50":false,"serum_m_reduction_ge_90":false,"electrophoresis_negative":false,"serum_m_reduction_25_to_49":false,"urine_m_reduction_50_to_89":false},{"imwg_pd":false,"bmpc_lt_5":true,"urine_m_pr":false,"urine_m_lt_100":false,"flc_ratio_normal":true,"ife_serum_negative":true,"ife_urine_negative":true,"no_clonal_cells_ihc":true,"plasmacytomas_absent":true,"serum_m_reduction_ge_50":false,"serum_m_reduction_ge_90":false,"electrophoresis_negative":false,"serum_m_reduction_25_to_49":false,"urine_m_reduction_50_to_89":false}]},"type":"http","method":"POST"},"output":{"type":"json","example":{"path":"/api/calc/imwg_response","count":2,"items":[{"cr_bits":true,"formula":"imwg_response","citation":{"id":"kumar-2016","doi":"10.1016/S1470-2045(16)30206-6","pmid":"27511158","title":"International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma","source":"Lancet Oncol. 2016;17(8):e328-e346","authors":"Kumar S, Paiva B, Anderson KC, Durie B, Landgren O, Moreau P, Munshi N, Lonial S, Bladé J, Mateos MV, Dimopoulos M, Kastritis E, Boccadoro M, Orlowski R, Zamagni E, Palumbo A, San Miguel J, Avet-Loiseau H, Goldschmidt H, van de Donk NWCJ, et al."},"criteria":[{"met":false,"factor":"imwg_pd"},{"met":true,"factor":"ife_serum_negative"},{"met":true,"factor":"ife_urine_negative"},{"met":true,"factor":"plasmacytomas_absent"},{"met":true,"factor":"bmpc_lt_5"},{"met":true,"factor":"cr_bits"},{"met":true,"factor":"flc_ratio_normal"},{"met":true,"factor":"no_clonal_cells_ihc"},{"met":false,"factor":"electrophoresis_negative"},{"met":false,"factor":"serum_m_reduction_ge_90"},{"met":false,"factor":"urine_m_lt_100"},{"met":false,"factor":"serum_m_reduction_ge_50"},{"met":false,"factor":"urine_m_pr"},{"met":false,"factor":"serum_m_reduction_25_to_49"},{"met":false,"factor":"urine_m_reduction_50_to_89"}],"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","imwg_response":"sCR","formula_expression":"Kumar 2016 IMWG measurable serum+urine M-protein response, first-match: PD if imwg_pd; else sCR iff CR_bits and flc_ratio_normal and no_clonal_cells_ihc; else CR iff CR_bits; else VGPR iff electrophoresis_negative or (serum_m_reduction_ge_90 and urine_m_lt_100); else PR iff serum_m_reduction_ge_50 and urine_m_pr; else MR iff serum_m_reduction_25_to_49 and urine_m_reduction_50_to_89; else SD. CR_bits = ife_serum_negative and ife_urine_negative and plasmacytomas_absent and bmpc_lt_5 (strictly <5% marrow plasma cells). Not FLC-only or nonsecretory. Not MRD. Not a diagnosis"},{"cr_bits":true,"formula":"imwg_response","citation":{"id":"kumar-2016","doi":"10.1016/S1470-2045(16)30206-6","pmid":"27511158","title":"International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma","source":"Lancet Oncol. 2016;17(8):e328-e346","authors":"Kumar S, Paiva B, Anderson KC, Durie B, Landgren O, Moreau P, Munshi N, Lonial S, Bladé J, Mateos MV, Dimopoulos M, Kastritis E, Boccadoro M, Orlowski R, Zamagni E, Palumbo A, San Miguel J, Avet-Loiseau H, Goldschmidt H, van de Donk NWCJ, et al."},"criteria":[{"met":false,"factor":"imwg_pd"},{"met":true,"factor":"ife_serum_negative"},{"met":true,"factor":"ife_urine_negative"},{"met":true,"factor":"plasmacytomas_absent"},{"met":true,"factor":"bmpc_lt_5"},{"met":true,"factor":"cr_bits"},{"met":true,"factor":"flc_ratio_normal"},{"met":true,"factor":"no_clonal_cells_ihc"},{"met":false,"factor":"electrophoresis_negative"},{"met":false,"factor":"serum_m_reduction_ge_90"},{"met":false,"factor":"urine_m_lt_100"},{"met":false,"factor":"serum_m_reduction_ge_50"},{"met":false,"factor":"urine_m_pr"},{"met":false,"factor":"serum_m_reduction_25_to_49"},{"met":false,"factor":"urine_m_reduction_50_to_89"}],"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","imwg_response":"sCR","formula_expression":"Kumar 2016 IMWG measurable serum+urine M-protein response, first-match: PD if imwg_pd; else sCR iff CR_bits and flc_ratio_normal and no_clonal_cells_ihc; else CR iff CR_bits; else VGPR iff electrophoresis_negative or (serum_m_reduction_ge_90 and urine_m_lt_100); else PR iff serum_m_reduction_ge_50 and urine_m_pr; else MR iff serum_m_reduction_25_to_49 and urine_m_reduction_50_to_89; else SD. CR_bits = ife_serum_negative and ife_urine_negative and plasmacytomas_absent and bmpc_lt_5 (strictly <5% marrow plasma cells). Not FLC-only or nonsecretory. Not MRD. Not a diagnosis"}]}},"iconUrl":"https://api.magentlab.com/favicon.ico"},"schema":{"type":"object","$schema":"https://json-schema.org/draft/2020-12/schema","required":["input"],"properties":{"input":{"type":"object","required":["type","method"],"properties":{"body":{"type":"object","required":["items"],"properties":{"items":{"type":"array","items":{"type":"object","required":["imwg_pd","ife_serum_negative","ife_urine_negative","plasmacytomas_absent","bmpc_lt_5","flc_ratio_normal","no_clonal_cells_ihc","electrophoresis_negative","serum_m_reduction_ge_90","urine_m_lt_100","serum_m_reduction_ge_50","urine_m_pr","serum_m_reduction_25_to_49","urine_m_reduction_50_to_89"],"properties":{"imwg_pd":{"type":"boolean","description":"Progressive disease as assigned by the caller using IMWG PD rules (Kumar 2016). true or false. When true, response is PD regardless of CR or M-protein reduction flags. magent does not compute PD from serial M-protein, FLC, or imaging values."},"bmpc_lt_5":{"type":"boolean","description":"<5% plasma cells in bone marrow aspirates as assigned by the caller (Kumar 2016 CR; strictly fewer than 5%, not ≤5%). true or false. magent does not read a marrow."},"urine_m_pr":{"type":"boolean","description":"Reduction in 24 h urinary M-protein by ≥90% or to <200 mg per 24 h, as assigned by the caller as this one flag (Kumar 2016 PR). true or false. magent does not assay urine M-protein."},"urine_m_lt_100":{"type":"boolean","description":"Urine M-protein <100 mg per 24 h as assigned by the caller (Kumar 2016 VGPR). true or false. magent does not assay urine M-protein."},"flc_ratio_normal":{"type":"boolean","description":"Normal serum free light-chain ratio as assigned by the caller (Kumar 2016 sCR). true or false. magent does not assay free light chains."},"ife_serum_negative":{"type":"boolean","description":"Negative immunofixation on serum, as assigned by the caller (Kumar 2016 CR). true or false. magent does not perform immunofixation."},"ife_urine_negative":{"type":"boolean","description":"Negative immunofixation on urine, as assigned by the caller (Kumar 2016 CR). true or false. magent does not perform immunofixation."},"no_clonal_cells_ihc":{"type":"boolean","description":"Absence of clonal cells in bone marrow biopsy by immunohistochemistry as assigned by the caller (Kumar 2016 sCR). true or false. magent does not read immunohistochemistry."},"plasmacytomas_absent":{"type":"boolean","description":"Disappearance of soft-tissue plasmacytomas, as assigned by the caller (Kumar 2016 CR). true or false. magent does not read imaging or examine plasmacytomas."},"serum_m_reduction_ge_50":{"type":"boolean","description":"≥50% reduction of serum M-protein from baseline as assigned by the caller (Kumar 2016 PR). true or false. magent does not assay M-protein."},"serum_m_reduction_ge_90":{"type":"boolean","description":"≥90% reduction in serum M-protein from baseline as assigned by the caller (Kumar 2016 VGPR). true or false. magent does not assay M-protein."},"electrophoresis_negative":{"type":"boolean","description":"Serum and urine M-protein detectable by immunofixation but not electrophoresis, as assigned by the caller (Kumar 2016 VGPR). true or false. magent does not perform electrophoresis."},"serum_m_reduction_25_to_49":{"type":"boolean","description":"≥25% but ≤49% reduction of serum M-protein from baseline as assigned by the caller (Kumar 2016 MR). true or false. magent does not assay M-protein."},"urine_m_reduction_50_to_89":{"type":"boolean","description":"50–89% reduction of 24 h urine M-protein as assigned by the caller (Kumar 2016 MR). true or false. magent does not assay urine M-protein."}}},"maxItems":25,"minItems":1}},"additionalProperties":false},"type":{"type":"string","const":"http"},"method":{"type":"string","const":"POST"},"headers":{"type":"object","additionalProperties":{"type":"string"}}},"additionalProperties":false},"output":{"type":"object","required":["type"],"properties":{"type":{"type":"string"},"example":{"type":"object"}}}}}}},"description":"Kumar 2016 IMWG measurable serum+urine M-protein response. First-match PD, sCR, CR, VGPR, PR, MR, or SD from caller-assigned flags. sCR is CR plus normal FLC ratio and no clonal BM cells by IHC. CR is negative serum and urine IFE, no plasmacytomas, and BMPC <5%. VGPR is electrophoresis-negative or ≥90% serum M-protein reduction with urine M-protein <100 mg/24 h. Not a diagnosis. Not MRD. Not FLC-only. magent does not assay labs.","lastUpdated":"2026-09-28T15:13:01.376Z","serviceName":"magent","x402Version":2}]}}